Reperfusion Injury, Myocardial Clinical Trial
Official title:
Effects of Melatonin on Reperfusion Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Acute myocardial infarction is a major cause of mortality and morbidity. Primary percutaneous coronary intervention (pPCI) is currently the most effective treatment strategy in acute myocardial infarction. However, a sizable number of patients fail to restore optimal myocardial reperfusion, mostly because of the 'no-reflow' phenomenon. Melatonin is the chief indoleamine produced by the pineal gland, and a well-known antioxidant and free radical scavenger. Several studies have shown that melatonin protects against ischemia/reperfusion injury (IRI). In our previous study, melatonin markedly reduced infarcted area, improved cardiac function and reduced lactate dehydrogenase release in rats. The investigators planned to research the cardioprotective effects of intravenous melatonin administered prior to reperfusion and continued after restoration of coronary blood flow in patients with ST segment elevation myocardial infarction undergoing pPCI.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03591991 -
Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI
|
N/A | |
| Recruiting |
NCT06128993 -
Trans-coronary Cooling and Dilution for Cardioprotection During Revascularisation for ST-elevation Myocardial Infarction
|
N/A | |
| Completed |
NCT03500783 -
Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03939338 -
Combination With Treg Levels and CMR to Assess the Severity and Prognosis of Reperfusion Injury After PPCI in STEMI Patients
|
||
| Enrolling by invitation |
NCT05734612 -
The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury
|
Phase 3 | |
| Completed |
NCT05215743 -
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
|
Phase 1 |